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Disease association mapsAbstract Formal genetic maps are databases, represented as text or graphic ﬁgures, that can be
collected/organized/formulated and constructed for nearly any, and every, structural or functional
region of the genetic material. Though these maps are basically descriptive, their analysis can pro-
vide relevant crucial data that can be applied for different purposes in many ﬁelds. The more com-
prehensive these maps are the more signiﬁcant information that can be provided through their
analysis. Formal genetic maps comprise four main categories: physical maps detailing the structural
characteristics of different regions/sequences of both the nuclear and the mitochondrial genomes,
functional maps describing the varied functional potentials of the different components of the gen-
ome/transcriptome/proteome, experimental induced maps that are intentionally designed and con-
structed for speciﬁc purposes and constructed maps that are deduced and extracted from other
formal maps to serve particular targets that cannot be achieved solely by the constituent maps. For-
mal genetic maps have a wide spectrum of applications in all ﬁelds of human genetics including
basic genetics as well as medical genetics. The beneﬁcial impact of the different types of formal
genetic maps imposed their application in nearly all ﬁelds of medical genetics including basic/clin-
ical/diagnostic/therapeutic/prophylactic and applied genetics and made these maps indispensable
tools in research studies relevant to these ﬁelds.
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Formal genetic maps (Table 1) are databases aiming at provid-
ing important, beneﬁcial and crucial clues relevant to nearly all
ﬁelds of human genetics, including medical genetics. Progress
in delineation and analysis of structural organization of the
human genome generates a ﬂood of information leading to
characterization of new formal maps of speciﬁc DNA markers
and regions of both structural and functional signiﬁcance.
These maps represent bioinformatics databases that have a
crucial impact on many aspects of basic as well as clinical med-
ical genetics.2. Types of formal genetic maps
Formal genetic maps comprise two main groups: physical
genetic maps and constructed genetic maps. Physical genetic
maps reﬂect data that represent naturally occurring physical
situations of the genetic material, like chromosomal locations
of genes or chromosomal maps. Constructed genetic maps, on
the other hand, comprise data observed, collected and analyzedTable 1 Formal genetic maps.
Physical maps Functional maps Constructed ma
1. Genome maps
2. Gene maps
3. Transposon maps
4. Pyknon maps
5. Pseudogene maps
6. Telomere maps
7. Chromosome maps
1. Transcriptome maps
2. Regulatory RNA maps
3. piwiRNA maps
4. Proteome maps
5. Oncoprotein maps
1. Linkage map
2. Genotype m
3. Haplotype m
4. Phenotype m
5. Disease assofrom research studies, e.g., linkage maps, as well as data
generated through experimentally induced situations, e.g.,
radiation hybrid maps. However, it must be emphasized that
apart from some physical genetic maps, the differentiation
between the two groups of genetic maps is not absolute, con-
siderable overlap between physical and constructed maps do
exist and some types of genetic maps can be considered within
the context of both groups. For instance, linkage maps are
constructed based on data analyzed from inbreeding experi-
ments or offspring genotypes, but they also reﬂect physical sit-
uations of genes showing linkage during recombination. Also,
oncogene maps, for instance, can be considered within the con-
text of physical genetic maps since they represent speciﬁc struc-
tural components of the genome as well as within the context
of constructed genetic maps because they represent data col-
lected and constructed for particular purposes, e.g., diagnostic
approaches to cancer and predictive/prophylactic approaches
to individuals prone to have malignant tumors. Many different
types of genetic maps can be arbitrarily designed and
constructed for speciﬁc targets. Functional genetic maps, for
example, can be formulated to delineate speciﬁc regulatory/
intermediary/executive functions of speciﬁc structuralps Induced/experimental maps
s
aps
aps
aps
ciation maps
1. Inter-species hybridization maps
2. Restriction fragment length polymorphism maps
3. Radiation hybrid maps
4. Probe-speciﬁc maps
Formal genetic maps 103components of the genome/transcriptome/proteome for partic-
ular aims. Proteome maps, for instance, can be constructed
based on proteome components of distinctive genetic disorders
for diagnostic/prognostic/predictive purposes. They can also
be constructed by delineating proteome proﬁles of particular
genomes for comparative characterization of different proteo-
mes of studied organisms. Structural/functional genomic maps
are comprehensive databases regarding critical structural com-
ponents of the genome that mediate vital constitutive and reg-
ulatory functions responsible for maintaining many crucial
aspects of the genome including genome identity, integrity
and stability. These maps include pyknon maps, pseudogene
maps, transposon maps and telomere maps.
3. Classiﬁcation of formal genetic maps
Formal genetic maps can be classiﬁed into four main catego-
ries that are widely used in nearly all ﬁelds of basic, clinical,
diagnostic and experimental genetics. They include: the family
pedigree, physical maps, functional genetic maps, constructed
genetic maps and induced or experimental genetic maps
(Table 1). In addition, extension of the use of some of these
maps can have a marked impact on other ﬁelds of medical
genetics like therapeutic, prophylactic and applied genetics.
The number of genetic maps constructed based on certain data
related to the structural organization and functional specializa-
tion of the genetic material is, apparently, unlimited. Any sig-
niﬁcant genetic data can be mapped and used for speciﬁc
purposes. Construction of bioinformatic databases and com-
parative analysis of data represent the main applications of
formal genetic maps.
4. Applications of formal genetic maps
The bioinformatic databases are represented as, and included
within, different types of formal genetic maps that have a wide
range of applications in many ﬁelds of basic, clinical, diagnos-
tic, therapeutic, prophylactic and applied genetics. Construc-
tion of the family pedigree of patients with genetic diseases,
or of families seeking counseling advice, constitutes the ﬁrst
step in approaching patients and families having genetic disor-
ders, and represents the simplest and most direct of these appli-
cations. Genealogical analysis of data represented by
informative symbols of the pedigree allows for deriving rele-
vant genetic information, like the possible pattern of inheri-
tance, and to calculate recurrence risk ﬁgures in future
offspring.
Progress in analysis of the structural organization of the
human genome generates a ﬂood of information leading to
characterization of new formal maps of speciﬁc DNA markers
and regions of both structural and functional signiﬁcance.
These maps represent bioinformatic databases that can have a
crucial impact on many aspects of basic as well as of clinical
medical genetics. For instance, exome maps comprising
detailed information of exons of genes can be constructed
and used for both intra and inter-species comparative pur-
poses. Similarly, within the context of pathogenetics, compar-
ison of exome maps of patients with speciﬁc idiopathic genetic
disorders with those of normal subjects might represent a
promising approach that can have many predictive and diag-
nostic applications in clinical genetics. Other types of molecu-lar maps that can be constructed based on available as well as
on the rapidly accumulating databases of human genome
structure, e.g., introme maps, pyknon maps, transposon maps,
telomere maps and maps of pseudogenes, can also have a wide
spectrum of applications in many ﬁelds of medical genetics.
The signiﬁcant beneﬁcial effects and applications of struc-
tural genetic maps in different ﬁelds of medical genetics call
for construction of parallel databases of functional genetic
maps that characterize critical functional markers and trans-
criptionally active regions and sequences of the human gen-
ome. Examples of such functional maps can, for instance,
include proteome maps comprising both structural protein
and enzyme, or catalytic, protein databases. Comparative
analysis of these functional protein maps in normal subjects
and in patients affected with speciﬁc genetically-determined
disorders and idiopathic diseases caused by, still, unidentiﬁed
etiological mechanisms, might prove helpful in revealing the
underlying pathoproteomic abnormalities responsible for the
development of the speciﬁc pathophysiological alterations that
characterize the clinical phenotype of each of these diseases. In
addition, in a way similar to that of reverse engineering, com-
parative analysis of normal proteome maps and abnormal pro-
teome maps of speciﬁc genetic disorders can disclose
underlying pathogenetic mechanisms, pathotranscriptomic dif-
ferences and causative genetic mutations possibly involved in
mediating the pathogenesis and development of these
disorders.
Hypothetical applications of functional human genomic
maps in medical genetics can include a wide range of countless
diagnostic techniques and therapeutic approaches. Compara-
tive analysis of proteome maps of normal cells and those of
malignant cells can, for instance, depict functional deviations
of the genome in cancer cells and detect oncogenic proteins
synthesized and expressed by the malignant cell and responsi-
ble for pathogenesis and evolution of the malignant pheno-
type. Oncoprotein maps constructed from this information
would, certainly, have beneﬁcial impact on research studies
aiming at better, and proper, understanding of malignant
transformation through targeting pivotal oncoproteins that
initiate and promote the malignant phenotype of cancer cells.
They would, also, have similar signiﬁcant impact on research
studies aiming at designing and tailoring speciﬁc therapeutic
trials for challenging carcinogenesis through e.g., engineering
of monoclonal antibodies against relevant oncoproteins inside
intracellular compartments, as well as on cell membranes and
within the intercellular environment. Interruption of signaling
pathways involved in the mediation of many selective advanta-
geous functions of malignant cells, e.g., enhanced glycolysis,
metastasis and neovascularization, which depend on the syn-
thesis of speciﬁc oncoproteins could, probably, represent a
promising approach in treatment of cancer via disassembly
of metabolic and regulatory networks actively participating
in malignant transformation and evolution of the malignant
phenotype.
On the molecular level, comparative analysis of transcrip-
tome maps of messenger RNA and of different micro RNA
species in normal and in diseased subjects could offer remark-
able help in the diagnosis of genetic diseases characterized by
substantial genomic activities. Malignant cells express large
numbers of actively transcribed genes and detailed cancer-spe-
ciﬁc transcriptome maps could be constructed for pathologi-
cally distinct types of malignancies, thus allowing for better
104 M.S.Z. Salemunderstanding of the aberrant phenomena of differential sup-
pression of certain genes and of mass overexpression of speciﬁc
gene families, e.g., proto-oncogenes, in malignant cells. They
can also offer more information on the genic and inter-genic
pathogenetic and pathological mechanisms underlying the
development of speciﬁc types of cancer. Cancer-speciﬁc tran-
scriptome maps and oncoprotein maps constructed for patho-
logically distinct types of malignancies might offer rapid and
accurate diagnostic tools of these malignancies when com-
pared with corresponding maps of normal cells. Delineation
of the whole spectrum of proto-oncogenes and of oncogenes
in the human genome and construction of informative maps
detailing relevant databases of this spectrum remains, and rep-
resents, a prospective ultimate goal crucial for understanding
and designing radical therapies for cancer.
5. Developmental formal genetic maps
During embryonic and fetal development, and to much lesser
extent during early post-natal life, organ and tissue-speciﬁc dif-
ferential suppression of large numbers of certain sets of genes,
paralleled by selective expression and/or over-transcription of
similar numbers of other sets of genes, is indispensable for nor-
mal regulation, synchronization and progression of consecu-
tive processes of differentiation, specialization, growth and
development. Comparative analysis of genome, transcriptome
and proteome functional maps during each of these stages of
embryonic and fetal life could reveal the intimate correlations
between synchronized temporal regulation of these three com-
ponents and the genomic regulatory aspects of developmental
stages and reveal many obscure aspects of this critical period
of life. This information might prove helpful in understanding
genomic and genetic disturbances that predispose to the path-
ogenetic mechanisms and the pathophysiological alterations
that mediate and underlie the development of congenital mal-
formations. Comprehensive understanding of these aspects of
development represents a prerequisite step indispensable for
hypothesizing and designing effective prophylactic measures
and early therapeutic approaches against teratogenesis and
development of congenital malformations. Additionally, for-
mal analysis of databases of structural and functional genomic
and proteomic maps of fetal development can add, signiﬁ-
cantly, to our current vague and scanty knowledge of many,
still, unknown aspects of regulatory genetic mechanisms, par-
ticularly those of genetic and genomic imprinting and temporal
synchronization of mass suppression and activation of huge
numbers of genes that characterize development and
differentiation.
Constructed integrated formal genetic maps might be help-
ful for many purposes. Comparative analysis of integrated
maps constructed for transcriptome and oncoprotein proﬁles
of pathologically distinct types of malignancies might offer
rapid and accurate diagnostic tools of these tumors when com-
pared to corresponding maps of normal cells. Delineation of
tumor maps comprising the whole spectrum of proto-onco-
genes, oncogenes and tumor suppressor genes in the human
genome represents an ultimate objective and an indispensable
goal crucial for understanding pathogenetic mechanisms
underlying the development of cancer. Integration of these
maps with oncoprotein maps and their sequential analysis dur-
ing different stages of tumorogenesis would, undoubtedly,reveal dynamics of tumor progression and acquisition of the
different characteristics of the malignant phenotype of cancer
cells. Understanding these aspects is crucial for proper design-
ing of therapeutic approaches to cancer based on targeting
oncoproteins responsible for the development of the malignant
phenotype. The roles played by proto-oncogenes and tumor
suppressor genes in regulating vital cellular processes, like
the cell cycle and cell division, allow for proposing many hypo-
thetical assumptions regarding their possible therapeutic uses
as growth promoters in genetic disorders characterized by
defective/deﬁcient/disturbed cell growth/division like some
types of short stature. Similarly, the critical roles played by
speciﬁc sets of oncoproteins in mediating/maintaining/further-
ing some essential distinctive features of the malignant pheno-
type, e.g., neovascularization, allows for proposing their use as
therapeutic agents in disease states resulting from ischemic
injuries to different tissues, e.g., thrombotic strokes, coronary
obliterations and diabetic vascular diseases.
Computational analysis of bioinformatics databases repre-
sented by different types of formal genetic maps, whether for
comparative or predictive purposes, represents a real chal-
lenge. Not only because of lack of many pieces of information
necessary to complete these maps, but also due to paucity of
our knowledge as regards basic essential genetic mechanisms
that regulate the structural integrity and functional specializa-
tion of the genome as a whole. For instance, the nature of the
regulatory systems that master the highly conserved species-
speciﬁc genetic constitutions of all creatures, including the
human genome, is extremely vague, without any clues to the
possibility of disclosing the design or the components of the
genetic material responsible for it, or the mechanisms of their
action, even in the near future. Similarly, the signiﬁcance of
many puzzling and enigmatic phenomena regarding the known
detailed structure and actual functions of the genetic material
continues to be a matter of debate in spite of the many theories
and hypotheses trying to explain them. Examples of such phe-
nomena include genetic imprinting, transposon activity, apop-
tosis, metabolic adaptations, malignant transformation and
many others. However, the mechanism through which solid
biomolecules, notably nucleic acids and proteins, can conceive,
interpret and execute pre-programed biological processes that
are embodied within their structural conﬁguration remains on
the top of these unsolved enigmatic phenomena in biology
(Table 2).
6. Physical genetic maps
6.1. Genome sequence maps
Structural genomic maps reveal detailed structural organiza-
tion of both repetitive and non-repetitive regions of the gen-
ome. They reveal the details of the structure, sequence
pattern, distribution and arrangement of all genic and non-
genic components of the whole genome. These maps can be
constructed to delineate structural characteristics of any part
of the nuclear genome, nuclear genome maps, and the mito-
chondrial genome, the mitochondrial genome maps. Genome
sequence maps represent the speciﬁc base sequence of the
DNA of the whole genome. They include all speciﬁc features
of the DNA as regards the number and arrangement of the
bases along each strand, presence and distribution of single
Table 2 Applications of formal genetic maps.
Type of genetic map Relevance to medical genetics
1. Family pedigree Genealogical study reveals pattern of inheritance, type of genetic disease, participation of non-
genetic factors in pathogenesis of the disease, etc.
2. Structural genomic (DNA)
maps
Provide information on number and distribution of unique genic and unique tandem repeats of non-
genic parts or domains of DNA, intergenic regions and repetitive sequences, gene density, etc.
3. Functional genomic maps Provide information on distribution of functional genic sequences, non-functional sequences like
pseudogenes and duplicated non-functional genes, transposons, pyknons, mutable hot spots of
DNA, imprinting centers, etc.
4. Genomic structural
variants (SVs) maps
Reveals human genetic variations and their possible linkage with speciﬁc human diseases. Also, they
are of particular signiﬁcance in many ﬁelds of study of comparative and evolutionary genetics.
5. Ribonucleic acids (RNA)
maps
Constituent databases of structure and function of diﬀerent types of RNA: messenger RNA
(mRNA), ribosomal RNA (rRNA), transfer RNA (tRNA) and diﬀerent species of small or
microRNAs.
6. Transcriptome maps Provide databases of (mRNA): structural variations, rates of transcription, of translation and of
turnover and decay. Diﬀerential characteristic alterations of post-transcription modiﬁcations in
speciﬁc disease states. Comparative analysis of mRNA maps can reveal possible causative gene
mutations as well as possible underlying pathogenetic mechanisms.
7. Chromosome maps Reveal details of chromosome topology, e.g. type of chromosome, gene loci, distribution of
telomeres and of ribosomal gene repeats, chromatin type and variations, etc.
8. Gene maps Clarify the size, base sequence, number of exons and introns, distribution of hot spots and of CG
sites, sequence type and organization of promoter region of the gene, etc.
9. Proteome maps Depicts constituent structural and catalytic proteins. Speciﬁc proteome maps can be constructed for
speciﬁc states, e.g. oncoprotein maps of malignant cells. These can further be classiﬁed and
delineated according to speciﬁc tumor type, e.g. oncoprotein map of hypernephroma, multiple
myeloma, etc.
10. Linkage maps Reveal recombination frequency of diﬀerent types of genetic markers, e.g., genes/traits/proteins/
DNA markers, for identifying location of genes relative to each other on chromosomes, etc.
11. Haplotype maps Provide comparative data about inter-individual single nucleotide polymorphism to determine the
likely locations and haplotypes involved in pathogenesis of, or predisposition to, speciﬁc diseases,
reveal presence and incidence of linkage disequilibrium of certain haplotypes, etc.
12. Inter-species
hybridization maps
Allow for assigning or (mapping) speciﬁc genes to speciﬁc chromosomes and even to certain
chromosome segments.
13. Restriction fragment
length polymorphism
(RFLP) maps
Used for the diagnosis of point mutations that alter a restriction site, and for comparative purposes,
e.g. paternity testing.
14. Radiation hybrid maps Provide data about relative positions of speciﬁc genic and DNA markers on speciﬁc chromosomal
regions based on frequency of chromosomal breakage induced by radiation.
15. Probe-speciﬁc maps Reveal widespread inter-individual as well as inter-species and intra-species genomic and
transcriptomic diﬀerences, provide critical data for population, comparative, experimental and
evolutionary genetic studies and researches.
16. Genotype maps Correlate speciﬁc genotypes with speciﬁc disease states, thus providing crucial information relevant
to provisional clinical diagnosis, eﬀective prophylactic management and genetic counseling.
17. Phenotype maps Depicts pathognomonic diagnostic combinations of disease-speciﬁc signs and symptoms for
genetically-determined and genetically-mediated disorders.
Formal genetic maps 105nucleotide polymorphisms (SNP), presence and pattern of
distribution of different types of repetitive sequences and
additional characteristic structural organization feature of
the genome. In disease states, comparison of the patient’s
DNA sequence map with normal maps can reveal existing
point mutations e.g. transitions, transversions, frame shift-
ing, non-sense (truncation) mutations, etc. These maps are
used for recognition of genetic diseases caused by point
mutations, and as DNA markers in ID testing in forensic
medicine.
Nuclear genomic maps reveal speciﬁc DNA markers on the
gene level as well as on the whole genome level. DNA markers
are deﬁned repetitive sequences of the nuclear genome. They
might be short or long sequences ranging in size from few
nucleotides to thousands of nucleotides, most often located
in noncoding regions of the genome. DNA markers have
major diagnostic implications since they represent characteris-
tic structural features of speciﬁc regions of the genome. Theyhave, also, critical implications in comparative analysis of
genomic proﬁles of different species. DNA markers have pro-
ven to be extremely useful for localizing human disease genes
that comprise some of these markers within their sequences,
or genes located adjacent to, or near, them. Valuable DNA
markers include:
Restriction fragment length polymorphisms (RFLP)
Variable number of tandem repeat polymorphisms
(VNTRs)
Single nucleotide polymorphisms (SNP)
Long Interspersed Elements (LINE)
Short Interspersed Elements (SINEs).6.1.1. Restriction fragment length polymorphisms (RFLP)
Restriction fragment length polymorphism sequences (RFLPs)
or restriction site polymorphism are deﬁned by the presence or
106 M.S.Z. Salemabsence along the DNA of speciﬁc sites, called restriction sites,
for speciﬁc bacterial endonuclease restriction enzymes. These
enzymes break apart strands of DNA wherever they contain
certain nucleotide sequences which are characteristic of the
speciﬁc enzyme [see Section 8.2 of this article].
6.1.2. Variable number of tandem repeat polymorphisms
(VNTRs)
Variable number of tandem repeats is due to DNA markers
composed of a variable number of nucleotide sequences that
are repeated several times in non-coding regions of DNA. In
each case, the number of times a sequence is repeated may
vary, and each variant acts as an inherited allele, allowing their
use for personal or parental identiﬁcation. VNTRs comprise
two main families: microsatellites or repeats of sequences less
than about 5 base pairs in length and minisatellites composed
of longer sequence blocks. Applications of maps of the vari-
able number of tandem repeats include their use in population
and comparative genetic studies and their analysis for DNA
ﬁngerprinting in forensic medicine.
6.1.3. Single nucleotide polymorphisms (SNPs)
Single nucleotide polymorphisms are individual point muta-
tions, or substitutions of a single nucleotide, that do not
change the overall length of the DNA sequence in affected
regions. SNPs occur throughout an individual’s genome in
very large numbers. As of July 2013, dbSNP listed
62,676,337 SNPs in humans [1]. Much has been assumed about
the signiﬁcance of SNPs and their prospective uses in person-
alized medicine and other similar applications. Actually, apart
from their use as individual genome-speciﬁc markers useful for
comparative diagnostic purposes, e.g., DNA ﬁngerprinting,
SNPs maps have no other true or useful applications, and
statements regarding their prospective roles in genetic medicine
are non-sense assumptions ignoring the basic facts about
mechanisms underlying pathogenesis of genetic diseases and
the roles played by the proteome in their causation. There is
much confusion between the presence of SNPs as normal indi-
vidual, genome-speciﬁc, molecular markers and their relation
to development of speciﬁc genetic diseases, e.g., Alzheimer dis-
ease, sickle cell anemia and osteoporosis, because once a SNP
results in causation of a disease state it cannot be considered as
a normal molecular marker, rather it should be looked at as a
pathogenetic point mutation changing a normal codon to an
abnormal codon resulting in translation of a defective disease-
causing protein, or even total cessation of protein synthesisFig. 1 Schematic represenor synthesis of truncated protein products in the case of chang-
ing a functional codon by a SNP into a non-sense codon.
6.1.4. Long interspersed elements (LINE)
These are genetic elements found in the human genome and
other eukaryotic genomes. The human genome contains over
one million LINEs sequences representing nearly 17–19% of
the total genome size. The most abundant of these belong to
a family called LINE-1 (L1). These L1 elements are DNA
sequences that range in length from a few hundred to a few
thousand base pairs. A very minute portion (about 50 L1 ele-
ments) are functional genes having sizes about 6500 bp in
length and encoding three distinct proteins including an endo-
nuclease and a reverse transcriptase. The sequence diversity of
LINEs elements between individual human genomes make
them useful markers for DNA ﬁnger printing [2].
6.1.5. Short interspersed elements (SINEs)
Short interspersed elements (SINEs) are short DNA
sequences, about 100–400 base pairs, found in very high copy
numbers in the human genome and many other mammalian
genomes. Nearly, 10% (about 300 Mb) of the human genome
is composed of a single family of SINEs, known as the Alus.
Alu elements consist of a sequence averaging 260 base pairs
that contains a site that is recognized by the restriction enzyme
AluI. Most SINEs do not encode any functional molecules and
depend on the machinery of active L1 elements (reverse trans-
criptase system) to be transposed, accumulated by a copy and
paste mechanism and gets inserted and integrated into the gen-
ome at distinct locations. Like the sequences diversity of
LINEs elements between individual human genomes, SINES
elements are also useful markers for DNA ﬁnger printing [2].
6.2. Gene maps
The gene map is a descriptive representation of the detailed
structure, or the internal anatomy, of the gene. It reveals the
size of the gene or the number of nucleotides it has, the speciﬁc
base sequence of the whole gene comprising the promoter
region/the exons/introns and the terminal region. It delineates
also the number and the arrangement of exons and introns
along the gene (Fig. 1).
Gene maps are constructed for each gene to reveal the
structural organization of the gene which is mandatory for
the molecular diagnosis of pathogenetic alterations of gene
structure induced by mutations, whether caused by pointtation of the gene map.
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tions affecting few bases/one or more exons/one or more
introns, or even the whole gene in cases of deletions, duplica-
tions or rearrangements. Gene maps can be further classiﬁed
into exome maps detailing the number, structural organization,
sequence pattern, SNP distribution and functional codon pro-
ﬁle of all exons of the gene and introme maps detailing the
number, structural organization, sequence pattern, SNP distri-
bution and other intronic retrotransposed and repetitive ele-
ments of all introns of the gene.
These maps are used for the diagnosis of point, as well as,
small-sized and gross mutations of the gene, e.g., single orTransposons: methods of transposition (Lauren Solomon, Broad Institute of Harvard and MIT).multiple exon or intron deletions/insertions/inversions/ampliﬁ-
cations/improper crossing over during recombination. Point
and few nucleotide mutations are amenable to diagnosis by
gene sequencing techniques. Large mutations, on the other
hand, can be diagnosed by many techniques that depend on
the integrity of the base complementarity of the gene, e.g.,
Fluorescent In Situ Hybridization (FISH). Exome maps
can be constructed and used for both intra and inter-species
comparative purposes. Similarly, comparison of exome
maps of patients with speciﬁc genetic disorders with those
of normal subjects might prove to be a promising approach
that can have many diagnostic applications in clinical genet-
ics. Comparative analysis of speciﬁc exome maps of speciﬁc
disease genes can pinpoint the pathogenetic alteration(s)
underlying the causation of the disease thus revealing the
cause of the disease, the possible mechanisms involved in
its pathogenesis and might be useful in proposing and
designing effective/alleviating therapeutic approaches to the
disease.
6.3. Transposons maps
Transposons or transposable elements (TEs) (Fig. 1), compris-
ing nearly half of the human genome, are genomic sequences
found within the introns of most genes. While nearly all TEs
within introns appear harmless, some de novo intronic TEs
insertions do disrupt gene transcription and splicing and causedisease. It is unclear why some intronic TEs perturb gene tran-
scription whereas most do not. Transposons have the ability to
detach themselves from their genomic sites to be inserted at
other sites in the genome. Alternatively, transposon sequences
might make a copy of their selves and this copy gets inserted at
another site along the genomic DNA [3]. These ﬁndings sug-
gest that transposon activity may represent an important cause
of spontaneous genomic mutations capable of inducing genetic
damage and instability of the genome. The role played by
transposons or transposable elements in inducing certain types
of spontaneous mutations, transposition or insertional muta-
tions, is well known in bacteria [4].The role played by increased transposon activity in causing,
seemingly, spontaneous mutagenic events that predispose to
developmental malformations during fetal development
deserves more attention if effective prophylactic and therapeu-
tic anti-teratogenic measures are to be reasonably hypothe-
sized and properly designed. Also, the effective opposition of
this teratogenic mechanism by the silencing action exerted by
P-element induced wimpy testis, Piwi-interacting RNAs
(piwiRNAs) or piRNA, which is the largest class of small
non-coding RNA molecules expressed in animal cells [5] on
transposon regulatory sequences, represents an important reg-
ulatory mechanism responsible for maintaining genomic integ-
rity and genomic stability during this critical period of life.
Construction of structural maps of transposons (transposon
maps) seems mandatory because comparison of malforma-
tion-speciﬁc transposon maps with their normal counterparts
would offer invaluable information which can be used to con-
struct anomaly-speciﬁc databases correlated with these partic-
ular transposon maps that depict speciﬁc overexpressed
transposons in speciﬁc types of congenital malformations.
These databases could have predictive value in delineating mal-
formation-causing transposons and might prove useful for pre-
natal diagnosis of these malformations. Further, they might
also prove to be important as potential therapeutic/prophylac-
tic applications by choosing and designing proper and speciﬁc
piRNA silencing molecules against these particular anomaly-
causing transposons.
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Pyknons (Fig. 2) are short DNA sequences, about 20-22 nucle-
otides in length, widely distributed in both the inter-genic and
intronic regions of the nuclear genome of human as well as in
the genomes of many other organisms, e.g., fruit ﬂy, chicken,
mouse, rat, and dog, the numbers of found human pyknons
in other species decrease with their phylogenetic distance.
Additionally, more than 90% of all human genes contain
one or more pyknon instances. More than 200.000 copies/
patterns of non-overlapping pyknons comprising nearly 900
million nucleotides of the human genome constitute about 1/
6th of the human genome. This makes them the most frequent,
variable-length DNA sequence motifs in the human genomes.
Pyknons have a remarkable degree of structural conservation.
Their presence in the 30 UTRs (un-translated regions) of genes
may indicate a potential regulatory role in posttranscriptional
processing and modiﬁcations of mRNA. Though they do not
share in either protein synthesis or RNA transcription, pyk-
nons are functional genetic elements associated with the medi-
ation of speciﬁc biologic cellular processes. They are putative
factors implicated in susceptibility to some common human
genetic disorders. Disturbed genomic regulation of function(s)
of pyknons might underlie the development of this genetic sus-
ceptibility [6]. The exceedingly large numbers of variable-
length pyknon patterns, their remarkable degree of structural
conservation, their widespread distribution in the genome,
their existence within coding genes, their putative roles in reg-
ulation of many cellular functions and in conferring suscepti-
bility to many genetic disorders would all make construction
of pyknon maps a worthy task for many reasons. First, they
can be used as individual-speciﬁc DNA markers for compara-
tive purposes, e.g., paternity testing and conﬁrmation of
genetic identity. Second, detection of, and correlation between,
characteristic patterns of pyknons in speciﬁc diseases might
offer a predictive/diagnostic approach to these diseases. Third,
the presence of pyknons in the genomes of other species in
varying proportions related to the phylogenetic diversity of
these genomes make them a valuable tool in comparative
and evolutionary genetic studies.
6.5. Pseudogene maps
Pseudogenes are dysfunctional altered copies of normal genes.
With very few exceptions, pseudogenes lack protein-codingFig. 2 Pyknons (wwability and their products are no longer expressed in the cell.
Though pseudogenes have varying degrees of sequence homol-
ogy to known genes, the true mechanisms underlying their
development are not clear, however they might result from
the accumulation of multiple mutations within a gene whose
product is not required for the survival of the organism. Trans-
fer of fragments of mitochondrial DNA to the nucleus, which
is a continuous and dynamic process particularly during
instances of DNA repair, and their incorporation as non-
encoded sequences in the nuclear genome account for the ori-
gin of a particular class of oncogenes referred to as nuclear
mitochondrial pseudogenes (NUMT-pseudogenes) [7] (Fig. 3).
There are four main types of pseudogenes, all with distinct
mechanisms of origin and characteristic features: processed or
retrotransposed pseudogenes, non-processed or duplicated
pseudogenes, disabled genes or unitary pseudogenes and
nuclear mitochondrial pseudogenes (NUMT-pseudogenes).
Although processed pseudogenes do not have introns or pro-
moters, where they are copied from mRNA and incorporated
into the DNA, most other pseudogenes have some gene-like
features such as presence of promoters, CpG islands and splice
sites. Pseudogenes differ from normal genes in lack of protein-
coding ability due to a variety of mutations affecting their pro-
moter regions and lack of transcription of mRNA. The DNA
of pseudogenes may be functionally similar to other kinds of
non-coding DNA which can have a regulatory role as evi-
denced by the ﬁnding of a retrotransposed pseudogene whose
transcript purportedly plays a trans-regulatory role in the
expression of its homologous gene. This ﬁnding suggests the
possibility of mediating important biological regulatory func-
tions by some pseudogenes [8]. This possibility is further sup-
ported by the identiﬁcation of some endogenous siRNAs that
appear to be derived from pseudogenes suggesting a role
played by these pseudogenes in regulating protein-coding tran-
scripts [9]. Additionally, mRNA levels of the tumor suppressor
PTEN gene and the oncogenic KRAS are affected by their
pseudogenes PTENP1 and KRASP1, respectively. This discov-
ery demonstrated the important functions of transcripts of
these pseudogenes as biologically active factors in tumor biol-
ogy; thus attributing a novel biological role to expressed pseu-
dogenes, as they can regulate coding gene expression, and
reveals a non-coding function for mRNAs in disease progres-
sion [10]. Of utmost importance, however, is the ﬁnding that a
processed pseudogene called phosphoglycerate mutase 3
(PGAM3P) actually produces a functional protein [11]. Thesew.junkdna.com).
Fig. 3 Pseudogenes in human genome (Mark Gerstein and Deyou Zheng: The real life of pseudogenes, 2006).
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genes raise many queries regarding the true signiﬁcance of
the presence of exceedingly large numbers of pseudogenes, that
may nearly equal the number of functioning genes, in the gen-
ome and their global distribution across all chromosomes.
Pseudogenes can complicate molecular genetic studies. For
example, ampliﬁcation of a gene by polymerase chain reaction
(PCR) may simultaneously amplify a pseudogene that shares
similar sequences. Also, nuclear copies of mitochondrial
DNA (mtDNA) can contaminate PCR-based mitochondrial
studies. This is known as PCR bias or ampliﬁcation bias. Sim-
ilarly, pseudogenes are sometimes annotated as genes in gen-
ome sequences. In addition, processed pseudogenes might
pose problems for gene prediction programs often being misi-
dentiﬁed as real genes or exons. It has been proposed that iden-
tiﬁcation of processed pseudogenes can help improve the
accuracy of gene prediction methods [12].
Construction of detailed maps of pseudogenes including
their types, distribution across the genome and their detailed
sequencing is important for many reasons:
First, in view of the problems ordained by pseudogenes in
diagnostic/predictive research studies these maps might be
helpful, as reference guides, to avoid or minimize confusing/
misleading results in this respect.
Second, the possible regulatory roles attributed to some
pseudogenes, that might be shared by more pseudogenes or
even be a common characteristic of most pseudogenes, neces-
sitate serious consideration of their roles in regulating gene
expression of normal genes including oncogenes and tumor
suppressor genes.
Third, the global genomic distribution of the exceedingly
large number of pseudogenes over all chromosomes contradicts
theoretical assumptions as regards the origin/non-functionality
of pseudogenes, as well as their unjustiﬁed classiﬁcation as junk
portions of the genome, because there is no point in keeping
such a considerable portion of non-functional components in
the genome. Construction of functional maps of pseudogenes
in the human genome would, certainly, reveal still undeﬁned
biological functions possibly mediated/affected/regulated by
transcripts or even protein products of some pseudogenes.Fourth, the development and formation of nuclear mito-
chondrial pseudogenes (NUMT-pseudogenes) entails inser-
tional mutagenic changes of the genome. Affection of
functioning genes by these pathogenetic changes can induce
structural disruption with consequent loss/suppression of func-
tion(s) of these genes. The ensuing pathobiochemical/patho-
physiological alterations secondary to deﬁciency of gene
product(s), whether being structural proteins/catalytic pro-
teins/regulatory RNA or other products, can mediate the path-
ogenesis of genetic disorders.
Development of diseases assumed to be related to, or attrib-
uted to, regaining function or dysfunction of some pseudo-
genes might occur and progress according to this
hypothesized pathogenetic mechanism. Accordingly, construc-
tion of integrated structural/functional maps of pseudogenes
might prove helpful in revealing and detecting some of the
mechanisms underlying the pathogenesis of these diseases.
6.6. Telomere maps
Telomeres are repeating sequences of DNA found at the ends
of chromosomes of most eukaryotic organisms. They are com-
posed of arrays of guanine-rich, six- to eight-base-pair-long
repeats, TTAGGG, varying greatly in number between species,
from approximately 300 base pairs in yeast to many kilobases
in humans. Eukaryotic telomeres normally terminate with a
30 single-stranded-DNA overhang, which is essential for telo-
mere maintenance and capping. Telomeres have twomain func-
tions in the genome. First, they prevent the ends of the
chromosome from fusion with other chromosomes thus main-
taining the chromosome number of the cell, which is a prerequi-
site for proper cell division. Second, they protect the ends of the
chromosomes from progressive shortening which occurs with
cell division because DNA replication does not continue to
the end of a chromosome. Hence, telomeres are replenished
by a telomerase enzyme system and compensate for incomplete
semi-conservative DNA replication at the chromosomal ends.
Mammalian somatic cells lacking telomerase gradually lose
telomeric sequences as a result of incomplete replication. As
the telomeres get shortened, the cell eventually reaches its rep-
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degenerative pathways involving the p53 and pRb pathways
leading ultimately to halting of cell proliferation and eventual
cell death [13]. Considered together, these functions of the telo-
meres are, undoubtedly, indispensable for preserving species-
speciﬁc genomic identity, integrity and stability.
In view of these ﬁndings, defective/deﬁcient functions of
telomeres are expected to induce a wide spectrum of pathoge-
netic alterations of affected cells including enhanced senes-
cence and aging, increased incidence of chromosomal
rearrangements and the development of cancer. A common
ﬁnding among different types of tumors is the presence/main-
tenance of telomerase activity in tumor cells to compensate for
the ongoing telomere shortening due to the rapid pace of cell
division of malignant cells. These cells use telomerase to extend
telomere lengths, allowing the tumor to continue its rapid
growth [14]. In light of this ﬁnding, abolishment of telomerase
activity via silencing of the telomerase gene might prove to be
an effective therapeutic approach to combat oncogenesis.
However, it must be realized that proper regulation of telome-
rase activity should be maintained since suppression of telome-
rase activity would result in enhanced shortening of telomeres
leading to premature aging and senescence. On the other hand,
persistent expression of telomerase for too long bears the risk
of increased incidence of tumor formation.
Construction of integrated telomere maps for speciﬁc cell
types comprising telomere lengths determined by e.g., quanti-
tative telomeric FISH technique, state of telomerase activity
and state of chromosomal stability identiﬁed by high resolu-
tion banding might be helpful as predictive parameters for
anticipating the development of cancer in predisposed individ-
uals having persistently maintained telomere lengths, high
expression levels of telomerase activity and chromosomal rear-
rangements commonly associated with tumor development,
e.g., increased incidence of chromosome breaks. Integration
of telomere maps with corresponding oncogene maps and,
more signiﬁcantly, with maps of oncoproteins would, proba-
bly, add more relevance to these predictive approaches to
carcinogenesis.
However, assumptions that attribute immortalization of
cancer cells and their extended proliferative potential and sur-
vival primarily to their ability to maintain high expression lev-
els of telomerase with corresponding maintenance of telomere
lengths of cancer cells [15] and postulations regarding roles of
telomeres in the regulation of gene expression and differentia-
tion of cancer cells [16] in addition to hypotheses relating telo-
mere lengths to aging, senescence, and development of age-
dependent pathological states [17] all ignore the critical roles
of factors, other than telomeres, directly implicated in initia-
tion and progression of age-related degenerative genomic
and cellular changes. These factors include, for example, the
predeﬁned programed apoptotic systems, the progressive
mutagenic burden of both the nuclear and the mitochondrial
genomes caused by continuous exposure to the damaging
effects of endogenous and exogenous mutagens, and the corre-
sponding intemperate deteriorating effects of these changes on
structure/organization/function of nuclear and cellular prote-
ome compartments responsible for maintaining pivotal proper
structural integrity and optimal functional potentials of
nuclear/mitochondrial/cellular components. Damaging and
degenerative effects of these factors include direct mutagenic
damage of genes responsible for regulating DNA replication/cell growth/cell division, direct mutagenic damage of tumor
suppressor genes, direct mutagenic damage of genes responsi-
ble for synthesis of proteins that mediate and regulate oxida-
tive-phosphorylation networks responsible for ATP
production, and degenerative/lethal alterations of structural/
intermediary/metabolic networks responsible for regulating
and maintaining vital cellular processes like signal transduc-
tion/trans-membrane transport/stability of cytoskeleton/cell
contact and interaction dynamics/protein modiﬁcation and
trafﬁcking/cellular secretory functions and many others. It is
obvious that any of these changes that are not dependent on,
or related to, telomere structure or function can have lethal
and drastic effects on the cell even to larger extent than defec-
tive telomere structure/function can induce. They can induce
arrest of DNA replication and impairment of cell division,
direct cell death, development of cancer, aging and senescence
due to progressive failure of cellular functions, defective struc-
tural organization of cell components and defective/deﬁcient
regulation of vital cellular functions. Unjustiﬁed over exagger-
ation of postulations regarding the roles of telomeres as guard-
ians of cell life might mask and/or underestimate the equally,
or even more, important roles of other genomic components
in maintaining life processes in the cell.
6.7. Chromosome maps
Chromosome maps reveal detailed structural organization of
different regions of the chromosomes. They comprise primarily
gene locus maps that deﬁne spatial localization of genes on
chromosome arms/bands/sub-bands/sub-sub-bands (Fig. 4).
Maps of chromosomal constitutional polymorphic markers
are relevant to studies of comparative and evolutionary genet-
ics since detecting striking variations of the most common of
these variants or cytogenetic markers, e.g., peri-centric inver-
sion of chromosome 9, polymorphisms of size and peri-centric
inversion of Y chromosome and polymorphisms (very small/
deﬁcient) of the heterochromatic regions of chromosomes,
revealed that the incidence of speciﬁc chromosomal variants
is different in each population group [18]. The signiﬁcance of
these maps of chromosomal polymorphic variants stems also
from ﬁndings pointing to role(s) of chromosomal inversions
in the development of adaptation, promotion of speciation
and reproductive isolation in natural populations [19].
Mapping of speciﬁc genes to particular chromosome
regions has been achieved through many approaches. Observa-
tion of sex differences in trait/disease phenotype is the simplest
of these approaches as it broadly classiﬁes genes into autoso-
mal and sex linked, X-linked and Y-linked, genes. Detection
of a persistent linkage between absence or presence of speciﬁc
chromosomal regions with the absence or presence of speciﬁc
gene products, e.g., proteins/immunoglobulins/hormones etc.,
e.g., chromosomal deletion studies, has been used to exclude
or verify mapping of genes encoding these products to these
chromosomal regions, respectively. Somatic cell hybridization
experiments or inter-species hybridization mapping (see Sec-
tion 7.1) had the greatest impact on constructing detailed chro-
mosomal maps of nearly each chromosomal segment of the
human genome and resulted in formulating comprehensive
maps of most gene loci located on chromosomes. Additional
approaches used for mapping genes and constructing chromo-
somal maps included linkage studies that indicate approximate
distances between genes on speciﬁc chromosomal regions,
Fig. 4 Gene locus maps of some chromosomes (www.soe.ucsc.edu/research/compbio/cytobands/).
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speciﬁc idiopathic genes to speciﬁc regions already having
genes including these markers, e.g., structural DNA markers,
or known to be responsible for coding these markers, e.g., bio-
chemical markers. Researches aiming at the detection of
hybridization and complementation between whole unpro-
cessed primary, or heterogeneous nuclear, mRNA molecules
to denatured single stranded genomic DNA might be helpful
in detection of putative genes responsible for transcribing these
mRNA molecules and in mapping them to speciﬁc sequences
of the genome.
7. Functional genetic maps
The signiﬁcant and beneﬁcial applications of structural genetic
maps in different ﬁelds of genetics including medical genetics
call for construction of parallel functional genetic maps that
characterize critical functional regions and transcriptionally
active domains of the human genome. Hypothetical applica-
tions of functional genomic maps can encompass a wide range
of prophylactic, diagnostic and therapeutic applications. For
instance, anticipation of possible complications in patients suf-
fering from speciﬁc genetic disorders, and of possible health haz-
ards in individuals with susceptible genetic backgrounds based
on formal genetic maps or databases of their genomic and pro-
teomic constitution, represents an important prophylacticapproach with favorable prognostic prospective in the manage-
ment of patients with speciﬁc genetic diseases and in offering
proper counseling advice to their concerned family members.
Functional genetic maps can be constructed for any func-
tional region of the genome. As stated previously, the differen-
tiation between physical or structural genetic maps and
functional genetic maps is not absolute Considerable overlap
between both types of maps do exist and some types of genetic
maps can be considered within the context of both groups.
Examples of vital functional genetic maps include exome
maps, transposon maps, pseudogene maps, pyknon maps, telo-
mere maps, transcriptome maps and proteome maps.
7.1. Transcriptome maps
On the molecular level, comparative analysis of transcriptome
maps of messenger RNA and of different micro RNA species
in normal and in diseased subjects could offer remarkable help
in the diagnosis of genetic diseases characterized by substantial
genomic activities. Malignant cells express large numbers of
actively transcribed genes and detailed cancer-speciﬁc tran-
scriptome maps could be constructed for pathologically distinct
types of malignancies, thus allowing for better understanding
of the aberrant phenomena of differential suppression of cer-
tain genes and of mass overexpression of speciﬁc gene families,
e.g., proto-oncogenes, in malignant cells. They can also offer
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mechanisms underlying the development of speciﬁc types of
malignancies as well as on the dynamics of tumor progression
based on comparative quantitative assays of tumor-speciﬁc
transcriptome maps and oncoprotein maps.
7.2. Proteome maps
Proteome maps comprise and delineate detailed information
databases of the whole set of proteins encoded by the whole
genome as regards: (1) Nature of protein components whether
they are structural proteins like cell cytoskeleton proteins, cat-
alytic proteins like enzymes or intermediary proteins like signal
transducing proteins. (2) Source of protein components
whether encoded by nuclear genes or mitochondrial genes (3)
Spatial localization in different compartments of the cell e.g.,
in cell membranes, cell pores, cell organelles, mitochondria,
cell nucleus, DNA-associated chromatin etc. (4) Function in
different cellular processes e.g., cell cycle regulating proteins,
membrane transport regulating proteins, signal transduction
mediating proteins, lysosomal/peroxisomal enzymes etc.
Attempts aiming at construction of comprehensive prote-
ome maps comprising the whole set of proteins in the cell
would, probably, have far reaching beneﬁcial impact on many
aspects of therapeutic genetics. For instance, comparative
analysis of proteome maps in normal and in subjects affected
with speciﬁc genetic disorders can identify disease-speciﬁc
defective/deﬁcient proteins responsible for pathogenesis of
these disorders. This diagnostic approach might prove partic-
ularly helpful for idiopathic genetic diseases, resulting from
deﬁcient synthesis of proteins or synthesis of defective pro-
teins, the causative genes of which are not yet identiﬁed. It
can also help in designing speciﬁc treatment approaches based
on detected proteomic changes, e.g. offering deﬁcient/defective
proteins to patients affected with these disorders.
Use of proteome maps in identifying still-undetected genes,
similar to reverse engineering techniques, might be worthy of
trial as a possible gene mapping approach. Computational
construction of possible mRNA codon sequences that can be
translated to speciﬁc proteins, combined with computational
construction of possible corresponding nucleotide sequences
that can be transcribed to the speciﬁc mRNA in question
might help in deﬁning most of the exome sequences of tran-
scribing genes in DNA sequence maps. Differentiation
between coding and non-coding sequences of DNA is a prere-
quisite before matching between both sequences due to pres-
ence of intronic sequences within the gene. Synthesis of a
complementary strand of the postulated exome sequence and
its use as a hybridization probe might indicate, in a more or
less approximate manner, possible localization/mapping of
the putative gene. Additionally, computational analysis of cor-
respondence between both sequences may be helpful in detect-
ing the most possible locus among detected loci.
7.3. Oncoprotein maps
Comparative analysis of proteome maps of normal cells and of
malignant cells can delineate and depict functional deviations
of the genome in cancer cells and detect oncogenic proteins
synthesized and expressed by the malignant cell. Construction
of oncoprotein maps comprising proteins responsible for path-ogenesis and evolution of the malignant phenotype would, cer-
tainly, have a beneﬁcial impact on research studies aiming at
better understanding of malignant transformations through
revealing pivotal oncoproteins that initiate and promote the
malignant phenotype of cancer cells. They would, also, have
a similar impact on research studies aiming at designing and
tailoring speciﬁc therapeutic approaches for challenging carci-
nogenesis through e.g., engineering of monoclonal antibodies
against relevant oncoproteins inside intracellular compart-
ments as well as on cell membranes and within intercellular
spaces/adhesion domains of malignant cells. Interruption of
signaling pathways involved in initiation/mediation/regulation
of selective advantageous characteristics and over expressed
functions of malignant cells, e.g., enhanced cell division/sup-
pressed apoptosis/enhanced glycolysis/neovascularization/
metastasis, through disassembly of metabolic/regulatory/inter-
mediary networks actively participating in malignant transfor-
mation and evolution of the malignant phenotype could,
probably, represent a promising approach in proposing and
designing effective treatment modalities of cancer.
7.4. Regulatory networks maps
Asall life activities in cells aremediated by a countless number of
regulatory networks, each comprising tens to hundreds of pro-
teins and other non-protein molecules, delineation of these net-
works and their constituent protein components and
construction of formal maps detailing their structure/function
relationship would be a major advance in understanding patho-
geneticmechanisms underlying disease pathogenesis and reveal-
ing the dynamics of pathophysiological alterations of different
stages of development of the disease phenotype. Construction
of regulatory networks involved in themodulation of gene func-
tions, apart from networks regulating proteome functions,
would also have a great impact on understanding mechanisms
of gene activation and factors involved in gene repression.
Recent studies aiming at generation and construction of a
genome-wide interaction map of regulatory elements in human
cells revealed that interactions between regulatory genomic ele-
ments play an important role in regulating gene expression.
The study also revealed that comparison of interactions
between cell types shows that enhancer–promoter interactions
are highly cell-type speciﬁc, thus revealing new mechanistic
and functional insights into regulatory region organization in
the nucleus [20]. The results of this study reveal the importance
of constructing maps of gene functions detailing the different
factors responsible for regulating gene function, whether
through activation or suppression. Assumptions regarding
possible uses of these factors to regulate and control gene func-
tions in treatment/alleviation/prevention of genetic disorders,
seem quite reasonable compared to classic gene therapy tech-
niques that drastically affect targeted genes in view of their
indiscriminate haphazard action and the major risks of result-
ing insertional mutagenesis.
8. Induced/experimental maps
8.1. Inter-species hybridization maps
The observation that genomes of some organisms have prefer-
ential selective advantages over genomes of other organisms
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on early attempts for mapping speciﬁc genes to certain chro-
mosomes. When somatic cells of two different species are
mixed together and exposed to the effect of certain cell mem-
brane fusing viral vectors, e.g., Sendai virus 40, in cell culture
media they combine together forming a single cell with a com-
mon fused nucleus called hybridoma. Somatic cell hybridiza-
tion experiments between different organisms revealed that
inter-species genomic selective advantage results in consequent
progressive loss of chromosomes of one organism with persis-
tence of the chromosomes of the other organism. Accordingly,
monosomic hybridomas for speciﬁc chromosomes with prote-
ome proﬁles deﬁned by the remaining chromosomes of the
hybridoma, result. Biochemical characterization of proteins
expressed by a distinctive hybridoma with unique chromo-
somal constitution combined with comparative analysis and
correlation of presence/absence of speciﬁc proteins with pres-
ence/absence of certain chromosomes of the hybridoma allows
for assigning/localizing/mapping of speciﬁc genes to speciﬁc
chromosomes and even to certain chromosome segments per-
sistently expressing proteins encoded by these genes in the cul-
ture media [21]. Though inter-species hybridization maps
constructed based on comparison/correlation analysis of
inter-species hybridoma experiments provide a crude technique
for gene localization and mapping of speciﬁc genes to speciﬁc
chromosomes, they have great impact on gene mapping tech-
niques as a prelude to delineate and construct chromosome
maps of, still, unlocalized genes (Figs. 5 and 6,).
8.2. Restriction fragment length polymorphism maps (RFLPs)
Synthesis of enzymes capable of breaking DNA is one, among
many, defense mechanisms whereby bacteria can damage
infecting viruses. These enzymes, or endonucleases, attack spe-
ciﬁc sequences present on double stranded DNA so that when-
ever these sequences, or restriction sites, exist along the DNA
molecule they got broken by the enzyme with the ultimate
result of fragmenting the target DNA into many fragments
that have peculiar numbers, sizes and distributions deﬁned
by the type of the endonuclease enzyme, the number ofFigs. 5 and 6 Inter-species hybrrestriction sites, their sequence speciﬁcity and their distribution
along the DNA strand. Restriction fragment length polymor-
phism maps are constructed by digestion of DNA by speciﬁc
endonucleases which target their speciﬁc restriction sites in
the DNA causing its break into a DNA–endonuclease peculiar
breakage pattern (Fig. 8). The resulting characteristic breakage
pattern, or fragment length polymorphism map, have many
applications, for instance, they can be used for diagnosis of
genetic diseases caused by point mutations that alter the
sequence of a restriction site leading to generation of a
different breakage pattern, e.g., sickle cell anemia. They can
also be used for comparative purposes, e.g., for paternity
testing [22].
8.3. Radiation hybrid maps (RH)
The mutagenic effects of particulate radiations on DNA lead-
ing to its breakage and fragmentation have been used to gen-
erate speciﬁc radiation-induced fragmentation pattern maps
based on the positive correlation between radiation dose and
DNA breakage index in human–rodent somatic cell hybrids
(Fig. 7). The differential susceptibility of chromosomes of each
cell type to the delivered radiation dose results in breakage of
the human chromosomes into fragments each having one or
more speciﬁc DNA markers. These fragments are subsequently
integrated into the rodent chromosomes. From these human–
rodent or donor–recipient hybrids, clones can be isolated and
tested for the presence or absence of DNA markers on the
human chromosome of interest, and the frequencies with
which markers were retained in each clone can be calculated.
The idea is based on a statistical method to determine not only
the distances between DNA markers but also their order on
the chromosomes. The concept of mapping is similar to the
underlying principle of mapping genes by linkage analysis
based on calculation of recombination events where the farther
apart two DNA markers are on a chromosome, the more likely
a given dose of X-rays will break the chromosome between
them and thus place the two markers on two different chromo-
somal fragments. The order of markers on a chromosome can
be determined by estimating the frequency of breakage that, inidization mapping technique.
Fig. 7 Technique of RFLP mapping (NCBI–NLM MeSH database resources).
Fig. 8 Principle of radiation hybrid mapping. (www.what-when-how.com/genomics).
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nique has been used to construct whole-genome radiation
hybrid maps [23].
8.4. Probe speciﬁc maps
These maps are constructed by hybridizing DNA to a large
panel of different probes prepared for multiple complementary
genomic markers. These maps can be applied to reveal wide-
spread inter-individual as well as inter-species and intra-species
differences, so they are critical for population genetic studies,
comparative genetic studies, experimental genetic researches
and evolutionary genetic studies. Probe speciﬁc maps might
prove useful in molecular diagnosis of genetic defects caused
by small/large mutations affecting marker sequences of the
genome. Comparative analysis of probe-speciﬁc maps of
DNA of normal and diseased individuals can reveal mutated
marker-including regions of the genome. They might alsoprove applicable for detection of chromosomal rearrange-
ments that result in physical interruption of speciﬁc marker
sequences involved in the rearrangements, thus leading to gen-
eration of a different probe speciﬁc map depending on the
chromosomal location of the marker(s) and the nature of the
chromosomal rearrangement [24,25].
9. Constructed genetic maps
9.1. Linkage maps
A linkage map is a genetic map of a certain species or experi-
mental population that shows the position of its known genes
or genetic markers relative to each other in terms of recombi-
nation frequency, rather than as speciﬁc physical landmarks
along each chromosome (Figs. 9 and 10). The greater the fre-
quency of recombination or segregation during crossover of
homologous chromosomes between two genetic markers, the
Figs. 9 and 10 Principles of linkage mapping techniques.
Formal genetic maps 115farther apart they are assumed to be. Conversely, the lower the
statistical frequency of recombination between the markers,
the smaller the physical distance between them. The genetic
markers that are used for constructing linkage maps for spe-
ciﬁc wild type normal genes or disease genes include different
types of markers, e.g., clinical markers (eye color), genomic
markers (minisatellites), biochemical markers (enzymes and
proteins), chromosomal markers (telomere maps), and molec-
ular markers (single nucleotide polymorphism).Genetic link-
age maps are not true physical maps, rather, they help
researchers to locate other markers, such as other genes, by
testing for genetic linkage of the already known genetic mark-
ers. Linkage mapping is critical for identifying the location of
genes that cause genetic diseases [26].
9.2. Genotype/haplotype maps
Genotype maps deﬁne the state of alleles that comprise the
genetic constitution of the individual. They include maps of
bi-allelic as well as poly-allelic traits and diseases. Genotype
maps reveal important data relevant to many aspects of basic
and clinical genetics. For instance, they comprise allele fre-
quencies, single nucleotide polymorphism (SNPs) and intronic
retrotransposed and repetitive sequences of each allele. Allele
frequency mapping is crucial for studies of population genetics
and genetic linkage studies, and SNPs are used for compara-
tive purposes. Genotype maps of patients suffering from spe-
ciﬁc diseases might have accurate diagnostic implications
when compared with normal maps for the same candidate dis-
ease genes. They also have important prophylactic applications
in pre-implantation diagnosis and in prenatal diagnosis as well.
Comprehensive genotype maps comprising the whole nucleo-
tide sequence and the characteristic structural variants of both,
or all, alleles of the gene represent a promising and reliable
approach for early detection and diagnosis of subjects with
susceptible genetic backgrounds, based on peculiar features
of their genetic constitution as detailed in their genotype maps.
9.3. Phenotype maps
Contrary to traditional restricted practices that conﬁne the
phenotype of a speciﬁc trait/disease to the clinical featuresobserved and detected, informative phenotype maps can be
constructed and formulated to include comprehensive repre-
sentation of relevant data of all possible phenotypic aspects
of speciﬁc genetic disorders. Thus, broad spectrum phenotype
maps constructed by integrating abnormal clinical ﬁndings,
family history, chromosomal aberrations, defective/deﬁcient
biochemical or proteome constitution, transcriptome altera-
tions and genome-wide molecular proﬁle(s) of speciﬁc diseases,
represent accurate and comprehensive disease-speciﬁc maps
that can offer reliable diagnostic approaches to these disorders.
9.4. Disease association maps
The persistent signiﬁcant association of speciﬁc disease states
with particular genetic markers could be interpreted in many
ways. First: participation of detected markers in pathogenesis
of the disease or in conferring susceptibility to its development.
Second: in the case of protein markers, the gene(s) causing the
disease and the marker-encoding gene may be affected/regu-
lated by the same factors (enhancers/suppressors) that control
gene expression. Third: tight physical linkage due to proximity
of loci on the same chromosomal region. Fourth: in the case of
sequence markers, e.g., pseudogenes or repetitive sequences,
the disease gene(s) might be physically related to the marker
sequences or regulated in a positive or negative manner by
the non-protein transcripts of these sequences. Fifth: associa-
tion of disease phenotype with particular non-related normal
phenotypic features, or abnormal phenotypic features of other
disease states, might indicate sharing exposure to developmen-
tal regulator networks or synchronized affection by develop-
ment-disturbing processes like increased transposon activity
or exposure to teratogenic agents, respectively.
Accordingly, construction and analysis of comprehensive
disease association maps could have a beneﬁcial impact on
researches aiming at clarifying the different and relevant
aspects of some of these aforementioned theoretical assump-
tions. Possible use of disease association maps as preliminary
predictive/diagnostic tools, through comparative analysis of
corresponding maps in normal individuals, and for mapping
unidentiﬁed disease gene(s) based on prior knowledge of map-
ping details of associated markers adds more merit to their
application in many ﬁelds of basic and clinical genetics.
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